Prevalence of glucose metabolism abnormalities and cardiovascular co-morbidity in the US elderly adult population

被引:8
作者
Varas-Lorenzo, Cristina [1 ]
de Castro, Ana Maria Rueda [1 ]
Maguire, Andrew [1 ]
Miret, Montserrat [1 ]
机构
[1] Novartis Farmaceut SA, Barcelona 08013, Spain
关键词
diabetes; glucose metabolism impairment; cardiovascular risk factors; elderly;
D O I
10.1002/pds.1229
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Purpose To estimate the prevalence of glucose metabolism abnormalities, including diabetes, and its associated cardiovascular risk factors and co-morbidity in the US elderly population. Methods Cross-sectional analysis of data from the Third National Health and Nutrition Examination Survey (NHANES 111, 1988-1994) in adults aged 65 years and more. The 1997 American Diabetes Association (ADA) and the 1998 World Health Organization (WHO) criteria were used to classify the subject's glucose metabolism status. The 2-hour oral glucose tolerance test (OGTT) was performed only among those participants aged 40 to 74 years. Results The age-adjusted prevalence of diagnosed diabetes was 12.5% (95% CI: 11.4%-13.6%) among US adults aged 65 years or more. According to the ADA definition 40% of men and 28% of women were affected by some degree of glucose metabolism impairment. According to the WHO definition, 55% of men and 50% of women aged 65 to 74 years were affected by glucose metabolism abnormalities. Mexican-Americans were the most affected under both definitions (51 % and 77%, respectively). Overall, 72% of elderly diagnosed diabetics had hypertension, 28% had coronary heart disease (CHD), 47% suffered from cardiovascular disease and 80% of them presented known CHD or multiple coronary risk factors, other than age, level of LDL-cholesterol and diabetes. Under both definitions, a trend towards a worsening coronary risk profile with increased glucose metabolism impairment was observed. Conclusion A notable proportion of elderly people is affected by some degree of glucose metabolism impairment which in turn is associated with cardiovascular co-morbidity. Copyright (c) 2006 John Wiley & Sons, Ltd.
引用
收藏
页码:317 / 326
页数:10
相关论文
共 32 条
[1]  
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[2]  
2-S
[3]   Diabetes mellitus, impaired fasting glucose, atherosclerotic risk factors, and prevalence of coronary heart disease [J].
Alexander, CM ;
Landsman, PB ;
Teutsch, SM .
AMERICAN JOURNAL OF CARDIOLOGY, 2000, 86 (09) :897-902
[4]  
*AM DIAB ASS, 1998, DIABETES CARE S1, V21, P523
[5]  
[Anonymous], 1982, MINNESOTA CODE RESTI
[6]  
[Anonymous], 1996, EX FIL 3 NAT HLTH NU
[7]   Isolated postchallenge hyperglycemia and the risk of fatal cardiovascular disease in older women and men - The Rancho Bernardo Study [J].
Barrett-Connor, E ;
Ferrara, A .
DIABETES CARE, 1998, 21 (08) :1236-1239
[8]   Cardiovascular disease in older adults with glucose disorders: comparison of American Diabetes Association criteria for diabetes mellitus with WHO criteria [J].
Barzilay, JI ;
Spiekerman, CF ;
Wahl, PW ;
Kuller, LH ;
Cushman, M ;
Furberg, CD ;
Dobs, A ;
Polak, JF ;
Savage, PJ .
LANCET, 1999, 354 (9179) :622-625
[9]   Prevalence of clinical and isolated subclinical cardiovascular disease in older adults with glucose disorders - The Cardiovascular Health Study [J].
Barzilay, JI ;
Spiekerman, CF ;
Kuller, LH ;
Burke, GL ;
Bittner, V ;
Gottdiener, JS ;
Brancati, FL ;
Orchard, TJ ;
O'Leary, DH ;
Savage, PJ .
DIABETES CARE, 2001, 24 (07) :1233-1239
[10]  
Borch-Johnsen K, 1999, LANCET, V354, P617